Stay updated on Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A banner was added announcing NIH updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-25T01:53:19.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page footer shows a newer site revision number.
    Difference
    0.2%
    Check dated 2026-10-18T01:39:17.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site footer’s revision identifier changed from v3.7.0 to v3.7.1, while the page still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T02:04:06.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Access to the study page NCT02365766 now returns a 403 Forbidden error, displaying a standard error page instead of the study content.
    Difference
    22%
    Check dated 2026-09-20T00:56:29.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.6, replacing v3.6.5. This indicates a system or template update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-08-29T20:07:56.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    The page's revision indicator was updated to Revision: v3.6.5. Several legacy sponsor, collaborator, and study document references were removed, resulting in a leaner Study Details page while preserving essential trial information.
    Difference
    20%
    Check dated 2026-08-08T19:26:54.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.